A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors-Reference-Cited by-同舟云学术

A phase II prospective study of sequential myeloablative chemotherapy with hematopoietic stem cell rescue for the treatment of selected high risk and recurrent central nervous system tumors

Published:2009-09-21 Issue:2 Volume:97 Page:247-255
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Rosenfeld Amy,Kletzel Morris,Duerst Reggie,Jacobsohn David,Haut Paul,Weinstein Joanna,Rademaker Alfred,Schaefer Colleen,Evans Lauren,Fouts Molly,Goldman Stewart

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-009-0009-z.pdf

Reference18 articles.

1. Mahoney DH, Strother D, Camitta B, Bowen T, Ghim T, Pick T, Wall D, Yu L, Shuster J, Friedman H (1996) High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. J Clin Oncol 14:382–388

2. Perez-Martinez A, Lassaletta A, Gonzalez-Vincent M, Sevilla J, Diaz A, Madero L (2005) High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 71:33–38

3. Modak S, Gardner S, Dunkel I, Balmaceda C, Rosenblum M, Miller D, Halpern S, Finlay J (2004) Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 22:1934–1943

4. George R, Li S, Medeiros-Nacarrow C, Neuberg D, Marcus K, Shamberger R, Pulsipher M, Grupp S, Diller L (2006) High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update. J Clin Oncol 24:2891–2896

5. Kletzel M, Katzenstein H, Haut P, Yu A, Morgan E, Reynolds M, Geissler G, Marymount M, Liu D, Kalapurakal J, Shore R, Bardo D, Schmoldt J, Rademaker A, Cohn S (2002) Treatment of high-risk neuroblastoma with triple-tandem high-dose therapy and stem cell rescue: results of the Chicago Pilot II Study. J Clin Oncol 20:2284–2292

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Strategy Involving High-Dose Chemotherapy with Stem Cell Rescue Followed by Intrathecal Topotecan Maintenance Therapy without Whole-Brain Irradiation for Atypical Teratoid/Rhabdoid Tumors;Pediatric Hematology and Oncology;2023-07-30

2. Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment;Cancers;2021-12-28

3. Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years;Cancer Research and Treatment;2021-04-15

4. Changes in glomerular filtration rate and clinical course after sequential doses of carboplatin in children with embryonal brain tumors undergoing autologous stem cell transplantation;Journal of the Egyptian National Cancer Institute;2020-02-18

5. Tandem high-dose chemotherapy with topotecan–thiotepa–carboplatin and melphalan–etoposide–carboplatin regimens for pediatric high-risk brain tumors;International Journal of Clinical Oncology;2019-07-27